Semaglutide is used in the treatment of type 2 diabetes mellitus.
🛒 How to order this item?
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Show More
Orsema 0.25mg is a glucagon-like peptide 1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus and to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes mellitus and established cardiovascular disease. Additionally, it is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index (BMI) of 30 kg/m² or greater (Obesity) or 27 kg/m² or greater (Overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia).
It is not known whether it is safe to consume alcohol with Orsema 0.25mg Subcutaneous Injection. Please consult your doctor.
Orsema 0.25mg Subcutaneous Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Information regarding the use of Orsema 0.25mg Subcutaneous Injectionduring breastfeeding is not available. Please consult your doctor.
It is not known whether Orsema 0.25mg Subcutaneous Injection alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Orsema 0.25mg Subcutaneous Injection is safe to use in patients with kidney disease. No dose adjustment of Orsema 0.25mg Subcutaneous Injection is recommended.
Orsema 0.25mg Subcutaneous Injection is safe to use in patients with liver disease. No dose adjustment of Orsema 0.25mg Subcutaneous Injection is recommended.
Type II Diabetes mellitus.
It is not known if Orsema 0.25 mg will cause thyroid tumors or medullary thyroid carcinoma (MTC) in people. Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath.
Safety and efficacy not established in pediatric patients.
No overall differences in safety or efficacy were detected between geriatric patients and younger patients.
No dose adjustment is recommended.
No dose adjustment is recommended.
Orsema 0.25 mg is a GLP-1 analogue with 94% sequence homology to human GLP-1. It acts as a GLP-1 receptor agonist, stimulating insulin secretion, lowering glucagon secretion, and delaying gastric emptying in a glucose-dependent manner.
Subcutaneous injection:
In the event of an overdose, appropriate supportive treatment should be initiated according to the patient’s clinical signs and symptoms.
Initiating Orsema 0.25 mg concomitant with an Insulin Secretagogue (e.g., Sulfonylurea) or with Insulin, consider reducing the dose of concomitantly administered insulin secretagogue (such as sulfonylureas) or insulin to reduce the risk of hypoglycemia. Caution should be exercised when oral medications are concomitantly administered with Orsema 0.25 mg.
Orsema 0.25 mg is contraindicated in patients with personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) and hypersensitivity to Orsema 0.25 mg.
Limited data are available. Use during pregnancy or breastfeeding only if the potential benefit justifies the potential risk.
Store your Orsema 0.25mg Subcutaneous Injection in the refrigerator at 2°C to 8°C (36°F to 46°F).
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.